Devonian Health【GSD】銘柄情報

Devonian Health Group Inc (GSD) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

7.17

( - )

買値

5.10

売値

10.00

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

19.939M

前日終値

7.17

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

$ 1,014

発行済株式数

2,780,866

配当利回り

PER

-3.31

1 株当たり利益 (EPS)

-2.26

歳入

純利益

-6.11M

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinic... Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis associated to radiotherapy, as well as in phase 2a clinical trial for ulcerative colitis. The company also develops Pantoprazole Magnesium for the treatment of gastric reflux; Cleo-35 for the treatment of hormonal acne in women; R-Spinasome anti-aging cream, serum, and regenerating creams; and anti-aging products, including day, night, and eye creams under the Purgenesis name. Devonian Health Group Inc. is headquartered in Québec, Canada. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

groupedevonian.com

本社

Québec, Canada

設立

Devonian Health Group Inc is listed in the Healthcare sector of the トロントベンチャー取引所 with ticker GSD. The last closing price for Devonian Health was $7.17. Over the last year, Devonian Health shares have traded in a share price range of $ 0.00 to $ 0.00.

Devonian Health currently has 2,780,866 shares in issue. The market capitalisation of Devonian Health is $19.94 million. Devonian Health has a price to earnings ratio (PE ratio) of -3.31.

Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026

Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30...

Devonian Reports Results of its Annual General and Special Meeting of Shareholders

Devonian Reports Results of its Annual General and Special Meeting of Shareholders Canada NewsWire QUÉBEC...

Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026

Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January...

Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

GSD - Frequently Asked Questions (FAQ)

What is the current Devonian Health Group Inc share price?

The current share price of Devonian Health Group Inc is $ 7.17

How many Devonian Health Group Inc shares are in issue?

Devonian Health Group Inc has 2,780,866 shares in issue

What is the market cap of Devonian Health Group Inc?

The market capitalisation of Devonian Health Group Inc is CAD 19.94M

What is the 1 year trading range for Devonian Health Group Inc share price?

Devonian Health Group Inc has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Devonian Health Group Inc?

The price to earnings ratio of Devonian Health Group Inc is -3.31

What is the cash to sales ratio of Devonian Health Group Inc?

The cash to sales ratio of Devonian Health Group Inc is 6.96

What is the registered address of Devonian Health Group Inc?

The registered address for Devonian Health Group Inc is 360, rue des Entrepreneurs, Québec, Quebec, G5V 4T1

What is the Devonian Health Group Inc website address?

The website address for Devonian Health Group Inc is groupedevonian.com

Which industry sector does Devonian Health Group Inc operate in?

Devonian Health Group Inc operates in the Biotechnology & Life Sciences sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Devonian Health Group Inc (GSD)

Devonian Health Group Inc (GSD) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Devonian Health Group Inc について

GSD 最新ニュース

Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026

Devonian Reports Results of its Annual General and Special Meeting of Shareholders

Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026

Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

Devonian reports additional molecular data from MASH liver study

DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY

DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT

DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING

Devonian Health Group Announces Grant of Stock Options

Devonian publie une mise à jour corporative et un complément d’information sur son placement privé préalablement annoncé

Devonian annonce la clôture d’un placement privé d’unités

GSD - Frequently Asked Questions (FAQ)

GSD 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Devonian Health Group Inc (GSD)

Devonian Health Group Inc (GSD) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Devonian Health Group Inc について

GSD 最新ニュース

Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026

Devonian Reports Results of its Annual General and Special Meeting of Shareholders

Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026

Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

Devonian reports additional molecular data from MASH liver study

DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY

DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT

DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING

Devonian Health Group Announces Grant of Stock Options

Devonian publie une mise à jour corporative et un complément d’information sur son placement privé préalablement annoncé

Devonian annonce la clôture d’un placement privé d’unités

GSD - Frequently Asked Questions (FAQ)

GSD 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS